The Exhale Podcast, brought to you by Vitalograph

The Exhale Podcast, brought to you by Vitalograph

Candid conversations about current matters relating to respiratory diagnostics and lung health.

Leveraging oscillometry for enhanced patient care in COPD

Dr. Frederik Trinkmann is the deputy head of Thoraxklinik at Heidelberg University.  Trained as a medical specialist for intensive care medicine.  He is a distinguished researcher with >60 publications. In this episode, he elaborates on his personal journey to adopting oscillometry and how he leverages oscillometry to make clinical decisions for enhanced patient care in COPD.
May 10, 2024

Episode # 57 Introducing FeNO

Karen Frankland, Lead Nurse for Education and Support, FeNO by NIOX NIOX has been at the forefront of FeNO testing for 25 years, and this year, Vitalograph is marking 60 years in respiratory diagnostics expertise. During these 60 years, Vitalograph has become synonymous with spirometry; and as an organization, it is continually looking at how it can enable better patient outcomes, with accurate, reliable data, through a range of diagnostic solutions. On today’s conversation, we are exploring Spirometry and FeNO testing. Specifically, how these tests provide physicians with a variety of data to inform asthma care pathways for patients. Karen Frankland is a primary care respiratory nurse specialist and qualified teacher with a wide range of experience within the N.H.S., occupational health, research, the pharmaceutical industry, and education. I have been involved in education, which is my passion! for approximately 20 years. Her current role is as Lead Nurse for Education and Clinical Support for The NIOX Group where I am responsible for the design and delivery of masterclass educational events on the topic of asthma and Fractional Exhaled Nitric Oxide Testing (FeNO). She also works with several other organizations and training providers, delivering training for a range of health care professionals. Topics include asthma, COPD, spirometry and FeNO. Organizations include M&K Update, Primary Care Respiratory Training Centre plus a few pharmaceutical companies.
November 2, 2023

Episode # 56 Let’s Talk About Chronic Cough: A Perspective from Patient Advocacy Partners

Kathy Przywara Vice President of Community at Asthma and Allergy Foundation of America Today we had a conversation with Kathy Przywara, Vice President of Community at Asthma and Allergy Foundation of America about Chronic Cough and her own experiences with chronic cough.   Kathy Przywara is the Vice President of Community at Asthma and Allergy Foundation of America (AAFA). She has worked in community management since 2005, managing and engaging groups of constituents. Her career has focused on community/patient engagement and support. She has extensive experience in community-building, digital content marketing, and social media.   Ms. Przywara served as the Assistant Community Manager of the Kids with Food Allergies Foundation (KFA) when that organization merged with AAFA in 2013. She brought her community building expertise to AAFA and helped launch AAFA’s award-winning asthma and allergy patient support community in 2016. Under her guidance, AAFA’s two online communities have grown to be the largest patient support communities available for these conditions. Asthma and Allergy Foundation of America
October 12, 2023

Episode # 55 The Application of HRF Inhibitor to Asthma Therapy

Toshiaki Kawakami, M.D., Ph.D. Professor, La Jolla Institute for Immunology Center for Autoimmunity and Inflammation We spoke with Professor Toshiaki Kawakami or Toshi as his colleagues and students call him. He is one of the leaders of La Jolla Institute for Immunology was established in 1988 by a coalition of leaders from academia and industry. These leaders envisioned a unique and dynamic partnership between basic science and applied research, one that would lead to breakthroughs in the understanding of the immune system and improve human health through the development of treatments and cures for immune system disorders. Dr. Toshia’s lab studies inflammatory diseases such as allergic asthma, food allergies and Crohn’s disease, which have been rising in prevalence for the last several decades. He is particularly interested in histamine-releasing factor (HRF) and its role in promoting inflammation in the lung and gut. La Jolla Institute for Immunology Center for Autoimmunity and Inflammation Website:  
August 30, 2023

Episode # 54 Pulmonary Fibrosis, An Advocate’s Story

Teresa Barnes, Chief Executive Warrior She first became involved with the PF community after losing five family members to IPF. Teresa began her career in journalism and has used those skills as she has navigated the worldwide PF community, seeking out-of-the-box solutions for treating PF. Teresa was a founder of the first IPF patient organization, the Coalition for Pulmonary Fibrosis back in 2001. She has served on multiple boards, including ATS, where she spearheaded multiple advocacy efforts. A member of PF Warriors for five years, Teresa will help us to open doors around the world. PF Warriors Website
August 16, 2023

Episode # 53 What is acute Respiratory Distress Syndrome (ARDS)?

Paula Blonski, President ARDS Alliance Rick Bressler, ARDS Survivor Today we had an interesting conversation with Paula Blonski, President-ARDS Alliance and Rick Bressler a patient who had Covid double lung pneumonia, Covid induced ARDS, but he ultimately needed a double lung transplant to survive.  Acute respiratory distress syndrome (ARDS) is an acute, diffuse, inflammatory form of lung injury and life-threatening condition in seriously ill patients, characterized by poor oxygenation, pulmonary infiltration, and acute onset.
August 2, 2023

Episode # 52 Trikafta and Me

Annaka Haynes is a nursing student who has had Cystic Fibrosis since she was 6 weeks old. Trikafta developed by Vertex Pharmaceuticals was first approved by the FDA on October 21, 2019. This treatment is a triple combination regimen for cystic fibrosis patients starting at ages 2 years and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation in the CFTR gene that is responsive to Trikafta based on in vitro data.
July 19, 2023

Episode # 51 How Asthma Diagnoses can be improved with precision medicine

Rory Chan (MBChB, MRCP(UK), PhD) is a senior respiratory registrar currently working in Ninewells Hospital, Dundee, United Kingdom Dr. Chan recently completed his PhD relating to precision medicine in severe asthma and has published more than 20 first-author peer reviewed papers in this area. He is a Honorary Clinical Lecturer at the University of Dundee, an Early Career Editor at CHEST, and the principal investigator of two phase IV biologic clinical trials in severe asthma.
July 5, 2023
View All Episodes

The Exhale Podcast, brought to you by Vitalograph

Welcome to Exhale, a podcast series discussing topical information about spirometry and respiratory care. Your hosts is Mark Russell, Marketing Communications Manager and Troy Pridgeon EVP of Sales and Operations for Vitalograph US, a global leader in respiratory diagnostics.


Mark Russell

Mark Russell

Mark Russell is the marketing communications manager at Vitalograph US, a global leader in respiratory diagnostics.
Troy Pridgeon

Troy Pridgeon

Troy Pridgeon is the EVP of sales and operations for Vitalograph US, a global leader in respiratory diagnostics.

You may also like

Join our community and never miss
your favorite episodes

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners